Trials / Unknown
UnknownNCT02414802
Study of a Novel Thrombectomy Device to Treat Acute Iliofemoral Deep Venous Thrombosis
Study on the Application of a Novel Aspiration Thrombectomy Device Combined With Catheter-directed Thrombolysis for the Treatment of Acute Iliofemoral Deep Venous Thrombosis
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Xuzhou Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether the novel aspiration thrombectomy device combined with catheter-directed thrombolysis is effective in the treatment of acute iliofemoral deep venous thrombosis (IF-DVT).
Detailed description
Catheter-directed thrombolysis will be performed in eligible patients with acute IF-DVT. A combined mechanical thrombectomy will be used to clear the iliac thrombi in experimental group. The immediate, mid- and long-term outcomes will be recorded. Quantitative data wiil be expressed as mean ± SD, and will be compared with independent-sample t-test or paired-sample t-test. Count data will be expressed as a ratio (or percentage), and the chi-square test or the fisher's exact test will be used for comparisons. A difference with P \< 0.05 will be considered statistically significant. All statistical analyses will be performed using IBM SPSS, version 22.0 (SPSS Inc., Chicago, IL, USA).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | a manual spiral thrombus broken suction device | A manual spiral thrombus broken suction device will be used for thrombectomy before catheter-directed thrombolysis |
| PROCEDURE | catheter-directed thrombolysis | catheter-directed thrombolysis will be used in both arms |
| DRUG | low-molecular-weight heparin calcium | anticoagulation therapy will be administered via subcutaneous injection of low-molecular-weight heparin calcium (LMWH-Ca 5,000 U/12 h) in both arms at discharge |
| DRUG | urokinase | A total of 100,000 units urokinase once every 4-6 hours will be used during catheter-directed thrombolysis therapy |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2017-12-01
- Completion
- 2017-12-01
- First posted
- 2015-04-13
- Last updated
- 2017-01-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02414802. Inclusion in this directory is not an endorsement.